Advertisement
Research Article

A Population-Based Evaluation of a Publicly Funded, School-Based HPV Vaccine Program in British Columbia, Canada: Parental Factors Associated with HPV Vaccine Receipt

  • Gina Ogilvie mail,

    gina.ogilvie@bccdc.ca

    Affiliation: University of British Columbia, Vancouver, Canada

    X
  • Maureen Anderson,

    Affiliation: BC Centre for Disease Control, Vancouver, Canada

    X
  • Fawziah Marra,

    Affiliation: University of British Columbia, Vancouver, Canada

    X
  • Shelly McNeil,

    Affiliation: Dalhousie University, Halifax, Canada

    X
  • Karen Pielak,

    Affiliation: BC Centre for Disease Control, Vancouver, Canada

    X
  • Meena Dawar,

    Affiliation: University of British Columbia, Vancouver, Canada

    X
  • Marilyn McIvor,

    Affiliation: BC Centre for Disease Control, Vancouver, Canada

    X
  • Thomas Ehlen,

    Affiliation: University of British Columbia, Vancouver, Canada

    X
  • Simon Dobson,

    Affiliation: University of British Columbia, Vancouver, Canada

    X
  • Deborah Money,

    Affiliation: University of British Columbia, Vancouver, Canada

    X
  • David M. Patrick,

    Affiliation: University of British Columbia, Vancouver, Canada

    X
  • Monika Naus

    Affiliation: University of British Columbia, Vancouver, Canada

    X
  • Published: May 04, 2010
  • DOI: 10.1371/journal.pmed.1000270

About the Authors

Gina Ogilvie, Fawziah Marra, Meena Dawar, Thomas Ehlen, Simon Dobson, Deborah Money, David M. Patrick, Monika Naus
University of British Columbia, Vancouver, Canada
Maureen Anderson, Karen Pielak, Marilyn McIvor
BC Centre for Disease Control, Vancouver, Canada
Shelly McNeil
Dalhousie University, Halifax, Canada

Corresponding Author

Email: gina.ogilvie@bccdc.ca

Competing Interests

SM is a member of the Canadian National Advisory Committee on Immunization. SD is presently a member of the British Columbia Immunization Sub-committee which advises the provincial government on practical issues related to the implementation of publicly funded immunization programs. From 2000 to 2008 SD was a member of the National Advisory Committee on Immunization for Canada. In 2008 SD attended an Advisory Board for Merck for a vaccine not yet licensed. This was not the vaccine used in the Provincial HPV vaccine program discussed in this paper. SD was paid an honorarium for my work on this advisory board.

Author Contributions

ICMJE criteria for authorship read and met: GO MA FM SM KP MD MM TE SD DM DMP MN. Agree with the manuscript's results and conclusions: GO MA FM SM KP MD MM TE SD DM DMP MN. Designed the experiments/the study: GO MA FM SM KP SD DMP MN. Analyzed the data: GO MA MD. Collected data/did experiments for the study: GO MA TE. Enrolled patients: GO MA MN. Wrote the first draft of the paper: GO. Contributed to the writing of the paper: GO FM SM KP MM TE SD DM DMP MN. Revision of document for important intellectual content, and approval of final version: MD. Reviewed the final version of the paper: SD.